Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm C Pike

Showing results (121-130 of 252) with videos related to

Pageof 26
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic DensityAnna H Wu, Darcy Spicer, Agustin Garcia, et al.
Cancer Research|December 21, 2006
A systematic assessment of common genetic variation in CYP11A and risk of breast cancerVeronica Wendy Setiawan, Iona Cheng, Daniel O Stram, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2011
Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boysCarol Davis-Dao, Chester J Koh, Brian E Hardy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Urinary estrogen metabolites and their ratio among Asian American womenRoni T Falk, Thomas R Fears, Xia Xu, et al.
Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2011
Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiologyCarol A Davis-Dao, Katherine D Henderson, Jane Sullivan-Halley, et al.
Scientific Reports|March 4, 2026
Evaluating mammographic density polygenic risk score for contralateral breast cancer risk predictionElnaz Naderi, Gordon P Watt, Julia A Knight, et al.
JNCI Cancer Spectrum|April 2, 2024
Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammographyGordon P Watt, Krishna N Keshavamurthy, Tuong L Nguyen, et al.
Journal of the National Cancer Institute|January 15, 2010
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009Carmen J Allegra, Denise R Aberle, Pamela Ganschow, et al.
International Journal of Cancer|March 22, 2022
Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholdsGordon P Watt, Julia A Knight, Tuong L Nguyen, et al.
Pageof 26

Showing results (121-130 of 252) with videos related to

Sort By:
Pageof 26
Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic DensityAnna H Wu, Darcy Spicer, Agustin Garcia, et al.
Cancer Research|December 21, 2006
A systematic assessment of common genetic variation in CYP11A and risk of breast cancerVeronica Wendy Setiawan, Iona Cheng, Daniel O Stram, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2011
Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boysCarol Davis-Dao, Chester J Koh, Brian E Hardy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Urinary estrogen metabolites and their ratio among Asian American womenRoni T Falk, Thomas R Fears, Xia Xu, et al.
Gynecologic Oncology|May 8, 2026
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosisAlexandra Lukey, Ali Salmanpour, Paramdeep Kaur, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2011
Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiologyCarol A Davis-Dao, Katherine D Henderson, Jane Sullivan-Halley, et al.
Scientific Reports|March 4, 2026
Evaluating mammographic density polygenic risk score for contralateral breast cancer risk predictionElnaz Naderi, Gordon P Watt, Julia A Knight, et al.
JNCI Cancer Spectrum|April 2, 2024
Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammographyGordon P Watt, Krishna N Keshavamurthy, Tuong L Nguyen, et al.
Journal of the National Cancer Institute|January 15, 2010
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009Carmen J Allegra, Denise R Aberle, Pamela Ganschow, et al.
International Journal of Cancer|March 22, 2022
Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholdsGordon P Watt, Julia A Knight, Tuong L Nguyen, et al.
Pageof 26